to evaluate the effectiveness of COVID-19 vaccine for the prevention of symptomatic, reverse transcription-polymerase chain reaction (RT-PCR) confirmed SARS-CoV-2 infection among healthcare workers in Kenya
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-033828
Grant search
Key facts
Disease
COVID-19start year
2021Known Financial Commitments (USD)
$600,000Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
United KingdomLead Research Institution
University of OxfordResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Health Personnel
Abstract
N/A